BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7614851)

  • 1. Cellular biology of tubulointerstitial growth.
    Wolf G; Neilson EG
    Curr Top Pathol; 1995; 88():69-97. PubMed ID: 7614851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia.
    Wolf G; Neilson EG
    Kidney Int; 1991 Mar; 39(3):401-20. PubMed ID: 1648145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury.
    Wolf G
    Miner Electrolyte Metab; 1995; 21(4-5):303-16. PubMed ID: 7565479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating factors of renal tubular hypertrophy.
    Wolf G
    Clin Investig; 1993 Oct; 71(10):867-70. PubMed ID: 8305851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular hypertrophy induced by angiotensin II.
    Wolf G; Ziyadeh FN
    Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different regulation systems of cell cycle events (dysregulation of these events in the tumoral cell)].
    Colomb E; Martin PM
    Bull Cancer; 1991 Jan; 78(1):1-21. PubMed ID: 2021683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophy and hyperplasia of renal tubular interstitial cells--regulatory factors].
    Kanetake H; Igawa T; Kanda S; Saito Y
    Nihon Rinsho; 1995 Aug; 53(8):1894-9. PubMed ID: 7563625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression.
    Ong AC; Fine LG
    Am J Kidney Dis; 1994 Feb; 23(2):205-9. PubMed ID: 8311076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of renal hypertrophy: role of p27Kip1.
    Wolf G
    Kidney Int; 1999 Oct; 56(4):1262-5. PubMed ID: 10504470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive factors and tubulointerstitial injury.
    Wolf G
    Kidney Blood Press Res; 1999; 22(1-2):62-70. PubMed ID: 10352409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of proto-oncogenes in coronary restenosis.
    Muller DW
    Prog Cardiovasc Dis; 1997; 40(2):117-28. PubMed ID: 9327828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells.
    Zeisberg M; Maeshima Y; Mosterman B; Kalluri R
    Am J Pathol; 2002 Jun; 160(6):2001-8. PubMed ID: 12057905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells.
    Li A; Wang J; Zhu D; Zhang X; Pan R; Wang R
    Free Radic Res; 2015; 49(9):1095-113. PubMed ID: 25968940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of diabetic renal hypertrophy.
    Wolf G; Ziyadeh FN
    Kidney Int; 1999 Aug; 56(2):393-405. PubMed ID: 10432377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
    Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
    J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.
    Djudjaj S; Martin IV; Buhl EM; Nothofer NJ; Leng L; Piecychna M; Floege J; Bernhagen J; Bucala R; Boor P
    J Am Soc Nephrol; 2017 Dec; 28(12):3590-3604. PubMed ID: 28801314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy.
    Abdel-Wahab N; Weston BS; Roberts T; Mason RM
    J Am Soc Nephrol; 2002 Oct; 13(10):2437-45. PubMed ID: 12239232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.